Neonatal herpes simplex virus infection

Clinical Obstetrics and Gynecology

Volumn 55, Issue 4, 2012, Pages 938-944

  Cherpes, Thomas L ^a   Matthews, Dean B ^a   Maryak, Samantha A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

herpes simplex virus infection; humoral immunity; neonatal transmission; pregnancy

Indexed keywords

ACICLOVIR;

ANTIVIRAL THERAPY; ARTICLE; BACTERIAL SHEDDING; COST EFFECTIVENESS ANALYSIS; HERPES SIMPLEX; HUMAN; INCIDENCE; INFANT MORTALITY; NEWBORN INFECTION; PATHOGENESIS; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UNITED STATES;

EID: 84868110452     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31827146a7     Document Type: Article

References (33)

1. Gutierrez KM, Halpern MSF, Maldonado Y, The epidemiology of neonatal herpes simplex virus in California from 1985 to 1995. J Infect Dis. 1999. 1999;180:199-202
2. Whitley R, Davis EA, Suppapanya N. Incidence of neonatal herpes simplex virus infections in a managed-care population. Sex Transm Dis. 2007;34:704-708.
3. Dinh T-H, Dunne EF, Markowitz LE, et al. Assessing neonatal herpes reporting in the United States, 2000-2005. Sex Transm Dis. 2008;35:19-21.
4. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203-209.
5. Xu F, Markowitz LE, Gottlieb SL, et al. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States. Am J Obstet Gynecol. 2007;196:e1-e6.
6. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296: 964-973.
7. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994;121:847-854.
8. Wald A, Corey L, Cone R, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997;99:1092-1097.
9. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992;116:197-202.
10. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and asymptomatic genital herpes infections. Ann Intern Med. 1995;333: 770-775.
11. Mostad SB, Kreiss JK, Ryncarz AJ, et al. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis. 2000;181:58-63.
12. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 1997;350:922-927.
13. Cherpes TL, Melan MA, Kant JA, et al. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis. 2005;40: 1422-1428.
14. Cherpes TL, Busch JL, Sheridan BS, et al. Medroxyprogesterone acetate inhibits CD8+ T cell viral specific effector function and induces herpes simplex virus type 1 reactivation. J Immunol. 2008;181:969-975.
15. Vicetti Miguel RD, Sheridan BS, Harvey SA, et al. 17-b estradiol promotion of herpes simplex virus type 1 reactivation is estrogen-receptor dependent. J Virol. 2010;84:565-572.
16. Frenkel LM, Garratty EM, Shen JP, et al. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med. 1993;118:414-418.
17. Brown ZA, Vontver LA, Benedetti J, et al. Genital herpes in pregnancy: risk factors associated with recurrences and asymptomatic viral shedding. Am J Obstet Gynecol. 1985;153:24-30.
18. Del Pizzo J. Focus on diagnosis: congenital infections (TORCH). Pediatr Rev. 2011;32:537-542.
19. Hangartner L, Zinkernagel RM, Hengartner H. Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol. 2006;6: 231-243.
20. Brown EL, Morrow R, Krantz EM, et al. Maternal herpes simplex virus antibody avidity and risk of neonatal herpes. Am J Obstet Gynecol. 2006; 195:115-120.
21. Lindsay MK. HSV neutralizing antibodies further refinement in preventing neonatal Herpes infection. Am J Obstet Gynecol. 2006;195:4-6.
22. KimberlinDW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108:223-229.
23. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108:230-238.
24. Engman ML, Adolfsson I, Lewensohn-Fuchs I, et al. Neuropsychologic outcomes in children with neonatal herpes encephalitis. Pediatr Neurol. 2008;38:398-405.
25. Kimberlin DW. Herpes simplex virus infections in neonates and early childhood. Semin Pediatr Infect Dis. 2005;16:271-281.
26. American Academy of PediatricsHerpes simplex. In: PickeringLK, ed. RedBook, 2009: TheReport ofThe Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics: 363-373.
27. ACOG Practice BulletinClinical management guidelines for obstetricians-gynecologists. No. 82. Management of herpes in pregnancy. Obstet Gynecol. 2007;109:1489-1498.
28. Whitley RJ, Corey L, Arvin A, et al. Changing presentation of herpes simplex virus infections in neonates. J InfectDis. 1988;158:109-116.
29. Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med. 2009;361: 1376-1385.
30. Arvin AM, Hensleigh PA, Prober CG, et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med. 1986;315:796-800.
31. Gardella C, Huang ML, Wald A, et al. Rapid polymerase chain reaction assay to detect herpes simplex virus in the genital tract of women in labor. Obstet Gynecol. 2010;115:1209-1216.
32. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2006;55:1-94.
33. Gardella C, Brown Z. Prevention of neonatal herpes. BJOG. 2011;118:187-192.